4-phenylamino-benzaldoxime derivatives and uses thereof as...

Details 4-phenylamino-benzaldoxime derivatives and uses thereof as... 4-phenylamino-benzaldoxime derivatives and uses thereof as...

2004-09-16

2011-12-27

Sullivan, Daniel (Department: 1621)

Organic compounds -- part of the class 532-570 series

Organic compounds

Amino nitrogen containing

C564S300000, C514S619000, C544S063000, C562S454000

Reexamination Certificate

active

08084645

ABSTRACT:
A compound of the present invention, or a pharmaceutically acceptable salt thereof is indicated by formula (1) below:wherein, R1, R2, R3, R4, R5, R6, Q, R8, and R9have the same meanings as R1, R2, R3, R4, R5, R6, Q, R8, and R9in the specification.

REFERENCES:
patent: 2967187 (1961-01-01), Serres, Jr. et al.
patent: 3725417 (1973-04-01), Holland
patent: 3821237 (1974-06-01), Malen et al.
patent: 4001420 (1977-01-01), Malen et al.
patent: 4469885 (1984-09-01), Mueller et al.
patent: 4501895 (1985-02-01), Mueller et al.
patent: 6440966 (2002-08-01), Barrett et al.
patent: 6750217 (2004-06-01), Barrett et al.
patent: 7001905 (2006-02-01), Biwersi et al.
patent: 7538120 (2009-05-01), Koch et al.
patent: 2003/0092748 (2003-05-01), Barrett et al.
patent: 2003/0225076 (2003-12-01), Biwersi et al.
patent: 2009/0233915 (2009-09-01), Isshiki et al.
patent: 2010/0197676 (2010-08-01), Isshiki et al.
patent: 1 262 176 (2002-12-01), None
patent: 1 144 385 (2005-08-01), None
patent: 1 674 452 (2006-06-01), None
patent: 1780197 (2007-05-01), None
patent: 46-015935 (1971-04-01), None
patent: 48-61448 (1973-08-01), None
patent: 59-210046 (1984-11-01), None
patent: 2002-534491 (2002-10-01), None
patent: 2002-534510 (2002-10-01), None
patent: 2002-332247 (2002-11-01), None
patent: 2003-527379 (2003-09-01), None
patent: 2007-504241 (2007-03-01), None
patent: WO 99/01426 (1999-01-01), None
patent: WO 00/35436 (2000-06-01), None
patent: WO 00/41994 (2000-07-01), None
patent: WO 01/68619 (2001-09-01), None
patent: WO02/06213 (2002-01-01), None
patent: WO 03/051877 (2003-06-01), None
patent: WO 2005/028426 (2005-03-01), None
patent: WO 2006/011466 (2006-02-01), None
Watson et al. J. Med. Chem. 2003, 46(15) 3181-3184.
C. Garcia-Echeverria and W. R. Sellers Oncogene (2008) 27, 5511-5526.
Shioi, T et al. Mol. Cell Biol. Apr. 2002; 22(8): 2799-809.
Patani et al. Chem. Rev. 1996, 96, 3147-3176.
Chardonnens et al., “256. Fluorènacènes et fluorènaphènes. Synthèses dans la série des indéno-fluorènes VIII.) Méthyl-3-, dimethyl-1,4-, diméthyl-1,3- et triméthyl-1,3,4-cis-fluorènacène,”Helv. Chim. Acta, 41:2436-2440 (1958).
Heintz et al., “Electrosynthesis of aryl-carboxylic acids from chlorobenzene derivatives and carbon dioxide,”Tetrahedron, 44:1631-1636 (1988).
LoRusso et al., “A phase 1 clinical and pharmacokinetic evaluation of the oral MEK inhibitor, CI-1040, administered for 21 consecutive days, repeated every 4 weeks in patients with advanced cancer,”American Society of Clinical Oncology Annual Meeting, Abstract No. 321, 2 pages (2002).
Mitchell et al., “Pharmacokinetics (PK) and pharmacodynamics (PD) of the oral MEK inhibitor, CI-1040, following multiple dose administration to patients with advanced cancer,”American Society of Clinical Oncology Annual Meeting, Abstract No. 320, 2 pages (2002).
Ozaki et al., “Studies on 4(1H)-Quinazolinones. 5. Synthesis and Antiinflammatory Activity of 4(1H)-Quinazolinone Derivatives,”J. Med. Chem., 28:568-576 (1985).
Japanese Patent Office, International Search Report for App. Ser. No. PCT/JP2005/013620, dated Nov. 22, 2005, 3 pages.
Japanese Patent Office, International Preliminary Report on Patentability for App. Ser. No. PCT/JP2005/013620, 6 pages.
Japanese Patent Office, International Search Report for App. Ser. No. PCT/JP2004/013501, mailed Dec. 28, 2004, 4 pages.
Japanese Patent Office, International Preliminary Report on Patentability for App. Ser. No. PCT/JP2004/013501, 6 pages.
European Search Report for App. Ser. No. EP 04 77 3160, dated Sep. 4, 2007 (2 pages).
Patani et al., “Bioisosterism: A Rational Approach in Drug Design,” Chem. Rev., 96:3147-3176 (1996).
USPTO Restriction Requirement in U.S. Appl. No. 11/658,533, mailed Oct. 28, 2009, 9 pages.
Fish & Richardson P.C., Third Preliminary Amendment and Response to Restriction Requirement dated Oct. 28, 2009 in U.S. Appl. No. 11/658,533, filed Dec. 28, 2009, 27 pages.
USPTO Notice of Allowance in U.S. Appl. No. 11/658,533, Jan. 28, 2010, 18 pages.

Affiliated with

Also associated with

Rating

4-phenylamino-benzaldoxime derivatives and uses thereof as... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 4-phenylamino-benzaldoxime derivatives and uses thereof as..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 4-phenylamino-benzaldoxime derivatives and uses thereof as... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4258369